First-of-its-kind clinical trial eliminates or shrinks melanoma tumors in 70% of patients

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

A clinical trial has shown that a new drug combination utilized before surgery completely eliminated or shrunk melanoma tumors in 70% of trial participants. The phase II clinical trial, NeoACTIVATE, enrolled patients with stage 3 melanoma; trial results were recently shared in a study published in Nature Communications.

First-of-its-kind clinical trial eliminates or shrinks melanoma tumors in 70% of patients retrieved 11 July 2024 from https://medicalxpress.com/news/2024-07-kind-clinical-trial-melanoma-tumors.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jun 5, 2024New study finds 40% of cancer cases and almost half of all deaths in the US linked to modifiable risk factorsUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in LAW

Law Law Latest News, Law Law Headlines